⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

April 9, 2024Neurology

A Wearable Movement Sensor Substudy of KINECT®-HD, a Phase 3 Trial of Valbenazine for the Treatment of Chorea Associated with Huntington’s Disease (P8-3.010)

Jamie Adams Erin Furr Stimming Daniel O. Claassen Elise Kayson Jody Goldstein Sean C. Hinton Olga Klepitskaya Hui Zhang Grace Liang Kelly Lin Sean M. Mitchell Dietrich Haubenberger

View Full Paper

Ask AI

Bookmark

Share

Abstract

To assess wearable sensor-derived changes in gait, posture, and chorea among KINECT®-HD trial participants.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Adams et al. (2024) studied this question.

synapsesocial.com/papers/68e6fdadb6db643587677c7a https://doi.org/10.1212/wnl.0000000000206214

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Sustained Improvements with Once-daily Valbenazine in Chorea Associated with Huntington’s Disease: Interim Results from a Long-term Open-label Study (S30.003)2024 · 1 citations
2Longitudinal assessment of chorea in Huntington’s disease using digital passive monitoringHuman Clinical Trial · 2026
3Using Wearable Sensors and Machine Learning to Assess Upper Limb Function in Huntington's Disease2024 · 2 citations
4Population Pharmacokinetic and Exposure-Efficacy Analyses of Valbenazine in Patients with Huntington's Disease: Supporting Dose Selection for Chorea Management.2025
5Huntington Disease and Chorea2025 · 5 citations